Published in J Pediatr Surg on July 01, 2001
Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res (2004) 2.38
Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia. J Clin Invest (2009) 2.08
α-enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia. Gastroenterology (2010) 1.82
The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis (2007) 1.74
Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol (2005) 1.51
Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology (2006) 1.44
Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology (2007) 1.39
Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med (2011) 1.23
Aetiology of biliary atresia: what is actually known? Orphanet J Rare Dis (2013) 1.18
Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum Mol Genet (2010) 1.17
Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology (2012) 1.16
Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest (2011) 1.13
Biliary atresia: recent progress. J Clin Gastroenterol (2008) 1.13
Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia. Liver Int (2008) 1.11
Biliary atresia. Semin Immunopathol (2009) 1.05
High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis. BMC Infect Dis (2005) 1.01
Clues to the etiology of bile duct injury in biliary atresia. Semin Liver Dis (2013) 1.00
Macrophages are targeted by rotavirus in experimental biliary atresia and induce neutrophil chemotaxis by Mip2/Cxcl2. Pediatr Res (2010) 1.00
Incidence of hepatotropic viruses in biliary atresia. Eur J Pediatr (2008) 0.98
Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia. BMC Gastroenterol (2006) 0.94
Biliary atresia: cellular dynamics and immune dysregulation. Semin Pediatr Surg (2012) 0.93
Biliary atresia. J Indian Assoc Pediatr Surg (2008) 0.92
Polymorphisms of the ICAM-1 gene are associated with biliary atresia. Dig Dis Sci (2008) 0.92
Progressive biliary destruction is independent of a functional tumor necrosis factor-alpha pathway in a rhesus rotavirus-induced murine model of biliary atresia. Viral Immunol (2007) 0.91
Association of circulating osteopontin levels with clinical outcomes in postoperative biliary atresia. Pediatr Surg Int (2010) 0.84
Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World J Gastrointest Pathophysiol (2010) 0.82
Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol (2015) 0.80
Biliary atresia: interdisciplinary initiatives focus on a rare disease. Pediatr Surg Int (2007) 0.80
CD 56 staining in liver biopsies does not help in differentiating extrahepatic biliary atresia from other causes of neonatal cholestasis. Diagn Pathol (2008) 0.80
Association of interferon-gamma gene polymorphisms in Taiwanese children with biliary atresia. J Clin Immunol (2009) 0.80
The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease. Hum Pathol (2014) 0.79
What Causes Biliary Atresia? Unique Aspects of the Neonatal Immune System Provide Clues to Disease Pathogenesis. Cell Mol Gastroenterol Hepatol (2015) 0.79
Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy. Pediatr Surg Int (2015) 0.78
Hepatic expression of multidrug resistance protein 2 in biliary atresia. Comp Hepatol (2011) 0.77
Rotavirus Infects Human Biliary Epithelial Cells and Stimulates Secretion of Cytokines IL-6 and IL-8 via MAPK Pathway. Biomed Res Int (2015) 0.77
Histological assessment of bile lake formation after hepatic portoenterostomy for biliary atresia. Pediatr Surg Int (2007) 0.76
Myofibroblastic cell activation and neovascularization predict native liver survival and development of esophageal varices in biliary atresia. World J Gastroenterol (2014) 0.75
There is no association between K469E ICAM-1 gene polymorphism and biliary atresia. World J Gastroenterol (2005) 0.75
Update on investigations pertaining to the pathogenesis of biliary atresia. Pediatr Surg Int (2017) 0.75
Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change? Pediatr Surg Int (2017) 0.75
Isolation and culture of biliary epithelial cells from bile duct remnants of patients with biliary atresia. Pediatr Surg Int (2004) 0.75
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet (1998) 3.33
Late referral for biliary atresia--missed opportunities for effective surgery. Lancet (1989) 3.27
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol (1982) 3.09
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr (1993) 2.32
Results of surgical treatment for extrahepatic biliary atresia in United Kingdom 1980-2. Survey conducted on behalf of the British Paediatric Association Gastroenterology Group and the British Association of Paediatric Surgeons. Br Med J (Clin Res Ed) (1985) 2.29
Congenital hepatoportal arteriovenous fistula. Surgery (1995) 2.14
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09
Open inguinal hernia repair with the use of polyglycolic acid/trimethylene carbonate absorbable mesh: a critical update of the long-term results. Hernia (2012) 2.06
Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet (1974) 1.97
Autoimmune hepatitis in childhood: a 20-year experience. Hepatology (1997) 1.97
Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr (1993) 1.96
Internal anal sphincter. Observations on development and mechanism of inhibitory responses in premature infants and children with Hirschprung's disease. Arch Dis Child (1968) 1.90
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86
Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut (1979) 1.83
Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med (1975) 1.82
Autonomic nerves in rectum and colon in Hirschsprung's disease. A cholinesterase and catecholamine histochemical study. Arch Dis Child (1969) 1.78
Open inguinal hernia repair with the use of a polyglycolic acid-trimethylene carbonate absorbable mesh: a pilot study. Hernia (2010) 1.78
Fetal ascites: an unusual presentation of Niemann-Pick disease type C. Arch Dis Child (1989) 1.77
Biliary atresia: the King's College Hospital experience (1974-1995) J Pediatr Surg (1997) 1.75
Hepatic 'stem cell' malignancies in adults: four cases. Histopathology (2003) 1.73
Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis. Gut (1978) 1.73
Cryosurgery of breast cancer. Arch Surg (1997) 1.71
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
The internal anal sphincter in the cat: a study of nervous mechanisms affecting tone and reflex activity. J Physiol (1974) 1.68
Adrenergic myenteric nerves in Hirschsprung's disease. Br Med J (1968) 1.67
Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med (1982) 1.64
Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Gastroenterology (1977) 1.61
Jaundice at 14 days of age: exclude biliary atresia. Arch Dis Child (1991) 1.61
Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet (1988) 1.60
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology (2001) 1.59
Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med (1989) 1.57
Xanthogranulomatous salpingitis: report of three cases and comparison with a case of pseudoxanthomatous salpingitis. Clin Exp Obstet Gynecol (2008) 1.56
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J (Clin Res Ed) (1982) 1.55
Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology (1993) 1.54
Increased hepatic copper concentration in Indian childhood cirrhosis. Lancet (1979) 1.54
Fulminant hepatic failure in childhood: an analysis of 31 cases. Arch Dis Child (1980) 1.53
Observations on preservation, bile drainage and rejection in 64 human orthotopic liver allografts. Ann Surg (1977) 1.53
Benign non-traumatic inflammatory strictures of the extrahepatic biliary system. Br J Surg (1989) 1.52
Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma. Am J Gastroenterol (1995) 1.51
Chronic liver disease developing after outbreak of HBsAG-negative hepatitis in haemodialysis unit. Lancet (1975) 1.49
Incarceration of umbilical hernias in children: a rare but important complication. Pediatr Surg Int (1998) 1.49
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
Choledochal cysts: lessons from a 20 year experience. Arch Dis Child (1995) 1.48
Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol (1979) 1.47
Orcein-positive liver deposits in Indian childhood cirrhosis. Lancet (1978) 1.47
Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol (1992) 1.46
Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin. Br Med J (1978) 1.46
Results of surgery in 88 consecutive cases of extrahepatic biliary atresia. J R Soc Med (1982) 1.45
Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol (1993) 1.43
Hemangioendothelioma of the liver in infants. J Pediatr Surg (1995) 1.42
Detection of HBSAG in fixed liver tissue - use of a modified immunofluorescent technique and comparison with histochemical methods. Gut (1976) 1.42
Accelerated development of alcoholic cirrhosis in patients with HLA-B8. Lancet (1982) 1.42
Halothane-induced acute liver failure: continuing occurrence and use of liver transplantation. Eur J Gastroenterol Hepatol (1998) 1.41
Biliary atresia splenic malformation syndrome: an etiologic and prognostic subgroup. Surgery (1993) 1.41
Pancreatitis in childhood associated with villous adenoma of the ampulla of Vater. Br J Surg (1996) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Microbial structures in a patient with sporadic non-A, non-B fulminant hepatitis treated by liver transplantation. J Med Virol (1987) 1.39
Changing pattern of alcoholic liver disease in Great Britain: relation to sex and signs of autoimmunity. Br Med J (1977) 1.38
Antenatal diagnosis of congenital anomalies of the biliary tract. J Pediatr Surg (1998) 1.37
Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancet (1980) 1.37
Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J Inherit Metab Dis (2002) 1.37
Budd-Chiari Syndrome: clinical patterns and therapy. Q J Med (1982) 1.37
The prelaparotomy diagnosis of extrahepatic biliary atresia. Arch Dis Child (1983) 1.36
Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J (1975) 1.36
Extrahepatic biliary atresia. Recent developments in management. Arch Dis Child (1977) 1.35
Toga-like virus as a cause of fulminant hepatitis attributed to sporadic non-A, non-B. J Med Virol (1989) 1.34
Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology (1983) 1.32
Biliary amylase and congenital choledochal dilatation. J Pediatr Surg (1995) 1.31
De-novo autoimmune hepatitis after liver transplantation. Lancet (1998) 1.30
Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters. J Pathol (1975) 1.30
Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease. Br Med J (1976) 1.30
Choledochal cyst: a 14-year surgical experience with 36 patients. Br J Surg (1988) 1.29
Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet (1979) 1.28
Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis. Gut (1981) 1.27
Ocular abnormalities in Alagille syndrome. Ophthalmology (1999) 1.25
Gastric volvulus in childhood. J Pediatr Surg (1987) 1.25
Virus, liver and autoimmunity. Dig Liver Dis (2001) 1.24
Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study. Hepatology (1996) 1.23
Cell-mediated immunity to human Tamm-Horsfall glycoprotein in autoimmune liver disease with renal tubular acidosis. Br Med J (1974) 1.23
Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis. Clin Exp Immunol (1987) 1.23
Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology (1998) 1.21
Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg (1995) 1.20
Seamless management of biliary atresia in England and Wales (1999-2002). Lancet (2004) 1.19
Liver disease as presenting manifestation of Hodgkin's disease. Q J Med (1979) 1.19
Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology (1994) 1.19
Neonatal paracetamol poisoning: treatment by exchange transfusion. Arch Dis Child (1983) 1.18
Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med (1999) 1.17
Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut (1981) 1.17